MedTrace Logo

Probiotics to Promote Intestinal Health

NCT02046512 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2022-04-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effectiveness of bacteria called Lactobacillus GG, a Probiotic, in preventing the growth of resistant bacteria in the digestive tract in patients on broad spectrum antimicrobials.

Conditions

  • Communicable Diseases
  • Infection
  • Anti-Infective Agents
  • Therapeutic Uses
  • Pharmacologic Actions

Interventions

DIETARY_SUPPLEMENT

Probiotic

1 capsule containing 10 billion cells of Lactobacillus rhamnosus GG on a twice-daily basis

OTHER

Placebo

Sugar pill

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-10-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02046512 on ClinicalTrials.gov